These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1352900)

  • 1. Differential effects of dopamine D2 agonist quinpirole upon the dorsal immobility response in rats.
    Meyer ME; Meyer ME; Potter TJ; Van Hartesveldt C
    Pharmacol Biochem Behav; 1992 Jun; 42(2):257-9. PubMed ID: 1352900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of administration of dopamine D2 agonist quinpirole on exploratory locomotion.
    Mogenson GJ; Wu M
    Brain Res; 1991 Jun; 551(1-2):216-20. PubMed ID: 1680523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogenetic quinpirole treatment induces vertical jumping activity in rats.
    Kostrzewa RM; Guo J; Kostrzewa FP
    Eur J Pharmacol; 1993 Aug; 239(1-3):183-7. PubMed ID: 7901028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-channel blockers attenuate the presynaptic effects of the D2/D3 agonist quinpirole in monkeys.
    Rosenzweig-Lipson S; Barrett JE
    Pharmacol Biochem Behav; 1995 Aug; 51(4):843-8. PubMed ID: 7675867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacological responsiveness to the dopamine agonist quinpirole in normal weanlings and in weanling offspring exposed gestationally to cocaine.
    Moody CA; Frambes NA; Spear LP
    Psychopharmacology (Berl); 1992; 108(3):256-62. PubMed ID: 1355920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-effective dose of exogenously applied L-dopa itself stereoselectively potentiates postsynaptic D2 receptor-mediated locomotor activities of conscious rats.
    Nakamura S; Yue JL; Goshima Y; Miyamae T; Ueda H; Misu Y
    Neurosci Lett; 1994 Mar; 170(1):22-6. PubMed ID: 7913743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dorsal striatal mechanisms involved in the dopamine D2 receptor-mediated potentiation of apomorphine-induced jaw movements.
    Kikuchi de Beltrán K; Koshikawa N; Miwa Y; Kobayashi M
    Eur J Pharmacol; 1994 Jan; 252(1):99-104. PubMed ID: 7908646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of biphasic locomotor effects of quinpirole.
    Van Hartesveldt C; Meyer ME; Potter TJ
    Pharmacol Biochem Behav; 1994 Jul; 48(3):781-6. PubMed ID: 7938135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microinjection of the D2 agonist quinpirole into the A10 dopamine region blocks amphetamine-, but not cocaine-stimulated motor activity.
    Steketee JD; Kalivas PW
    J Pharmacol Exp Ther; 1992 May; 261(2):811-8. PubMed ID: 1349649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic D1-receptor blockade: effects on D2-receptor agonist-induced yawning in rats.
    Hietala J; Lappalainen J; Syvälahti E
    J Pharm Pharmacol; 1991 Apr; 43(4):278-9. PubMed ID: 1676742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of alpha 1 receptors in the behavioural supersensitivity to D2 agonists induced by chronic treatment with imipramine.
    D'Aquila PS; Collu M; Gessa GL; Serra G
    Pharmacol Res; 1992 Jan; 25(1):95-101. PubMed ID: 1346718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue.
    Furmidge LJ; Exner M; Clark D
    Eur J Pharmacol; 1991 Sep; 202(2):191-9. PubMed ID: 1687032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effects of chronic treatment with antidepressant drugs and intermittent treatment with a dopamine agonist.
    Papp M; Muscat R; Willner P
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):121-5. PubMed ID: 1353000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The D2 agonist quinpirole potentiates the discriminative stimulus effects of the D1 agonist SKF 38393.
    Williams JE; Woolverton WL
    Pharmacol Biochem Behav; 1990 Oct; 37(2):289-93. PubMed ID: 1981936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosing regimen differentiates sensitization of locomotion and mouthing to D2 agonist quinpirole.
    Eilam D; Szechtman H
    Pharmacol Biochem Behav; 1990 Aug; 36(4):989-91. PubMed ID: 1977180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulatory effects of quinpirole hydrochloride, D2-dopamine receptor agonist, at low concentrations on prolactin release in female rats in vitro.
    Tagawa R; Takahara J; Sato M; Niimi M; Murao K; Ishida T
    Life Sci; 1992; 51(10):727-32. PubMed ID: 1355255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.